We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Nastech to Host Webinar on its RNAi Therapeutics Programs and siRNA Delivery Technology

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Nastech to Host Webinar on its RNAi Therapeutics Programs and siRNA Delivery Technology "

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Nastech Pharmaceutical Company Inc. has announced that it will host a Webinar concerning its emerging siRNA therapeutics programs and siRNA drug delivery technology. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO will present at the event.

What: RNAi webinar on the science and business of RNAi therapeutics followed by a Q&A session. Questions may be emailed in advance to rnaiwebinar@nastech.com or during the event through the webinar interface
When: Thursday, November 9, 2006, from 10:30-11:15 AM U.S. East Coast time

How: Live over the Internet FREE via a simple advanced registration online
Where: Webinar will be available online. once you are registered

If you are unable to participate during the live RNAi webinar webcast, an archive and replay will be available for 30 days via Nastech's website.

During the webinar, Dr. Quay will provide an overview of the exciting science behind RNAi and discuss the Company's rheumatoid arthritis and influence therapeutics programs as well as the Company's molecular biology based drug delivery technology.